Sponsor

Azienda Policlinico Umberto I

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Azienda Policlinico Umberto I appears in 11 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials11
Recruiting shown2
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

11 shown
DPP4-Inhibitors and Bone Metabolism in DiabetesNCT06770894 · lead sponsor · 2019-09-24
COMPLETED
An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens, Including NUC-sparing Regimens, in Aged HIV Patients.(RalAge)NCT03579485 · lead sponsor · 2018-01-31
UNKNOWN
An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens in Aged HIV Patients (RalAge)NCT02765776 · lead sponsor · 2016-05-01
COMPLETED
Radical Prostatectomy and External Beam Radiotherapy in mCRPC With 223Radium-dicloride (RaProRad)NCT04110782 · lead sponsor · 2015-09-01
UNKNOWN
Effects of VSL#3 on Neuro-cognitive Profile of HIV PatientsNCT02276326 · lead sponsor · 2014-07-01
COMPLETED
Comparison of Pulmonary Vein Isolation Versus AV Nodal Ablation With Biventricular Pacing for Patients With Atrial Fibrillation With Congestive Heart Failure (PABA CHF)NCT00599976 · lead sponsor · 2002-11-01
COMPLETED
Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world StudyNCT06240195 · collaborator · 2023-01-17
RECRUITING
Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiovascular Risk in Patients with Heart FailureNCT06884631 · collaborator · 2021-02-10
RECRUITING
Study of Transanal Irrigation vs Standard Care for Constipation, Gut Microbiota, and Motor Disorders in Parkinson's DiseaseNCT07716553 · collaborator · 2026-09-30
NOT_YET_RECRUITING
Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 TrialNCT05763992 · collaborator · 2023-05-15
UNKNOWN
Italian Lung Cancer Observational StudyNCT05851755 · collaborator · 2023-04-01
ENROLLING_BY_INVITATION

Drugs studied in this sponsor's trials

1 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Azienda Policlinico Umberto I as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Sponsor roles

lead sponsor6
collaborator5
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.